Congratulations to everyone, in special to Sandra! Well done!
1-Benzamido-1,4-dihydropyridine derivatives as anticancer agents: in vitro and in vivo assays, Ardevines, S.; Auria-Luna, F.; Romanos, E.; Fernández-Moreira, V.; Benedi, A.; Gimeno, M. C.; Marzo, I.; Marqués-López, E.; Herrera, R. P. Arab. J. Chem. 2022, 104514. https://doi.org/10.1016/j.arabjc.2022.104514.
Abstract. 1,4-Dihydropyridine is a privileged scaffold present in many bioactive molecules, from coenzymes to commercially available drugs. Among other interesting properties, it has been found good anticancer activity in some of these 1,4-DHPs, therefore many research groups are trying to develop new compounds based on this structural core.
For this purpose, in this work, a new family of 23 1,4-dihydropyridines has been synthesized using hydrazide and malononitrile derivatives as precursors. This straightforward catalytic process has given rise to the desired products with moderate to excellent yields. All the compounds have been tested against four different cancer cell lines [HeLa (human cervical carcinoma), Jurkat (leukemia), A549 (human lung cancer) and MIA PaCa-2 (pancreatic cancer)] to establish a preliminary structure-activity relationship. From this study, and among the best candidates, we chose 4-chlorophenyl and 4-thifluoromethylphenyl derivatives in the malononitrile ring to synthesize a second generation of molecules with enhanced cytotoxicity, modifying the substituent in the N-heterocyclic position (acylhydrazine moieties). With this second generation of compounds, we successfully decreased the IC50 until 7 µM.
An in-depth analysis of their biological properties suggests that these promising compounds trigger a non-conventional cell death mechanism known as paraptosis. Moreover, the tested photophysical properties of these products show in some cases an interesting long wavelength emission and excitation, potentially leading to new biosensors or theragnostic agents.
Finally, in vivo assays concerning the acute toxicity in mice of two of the most active compounds (with an alkyl chain of seven carbon atoms in the acylhydrazine moiety) demonstrated that even dosed at thousands fold the corresponding IC50 values (2500 and 3300 times more concentrated than the IC50 values for the two compounds studied), there was no sign of harmful effects to the tested subjects, results that support their use in further studies to discover new anticancer drugs.
Keywords. cancer; hydrazide; 1,4-dihydropyridine; in vitro; in vivo (mice); paraptosis; theranostic
This entry was posted in Cancer
and tagged 2022
, Andrea Benedi
, Arab. J. Chem.
, Eduardo Romanos
, Eugenia Marqués-López
, Fernando Auria-Luna
, Isabel Marzo
, M. Concepción Gimeno
, Raquel P. Herrera
, Sandra Ardevines Asín
, Vanesa Fernández-Moreira
. Bookmark the permalink